Esmolol effects on propofol requirement for hysterectomy
Phase 3
- Conditions
- patients who undergo hysterectomy.
- Registration Number
- IRCT20200928048871N1
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 45
Inclusion Criteria
ASA I and ASA II
individuals who are having total abdominal hysterectomy
Exclusion Criteria
beta blocker use contraindicatied
drugs and alcohol usage
thyroid problems
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The amount of propofol injected during the surgery. Timepoint: from the beginning till the end of surgery continuously. Method of measurement: measuring of the injected propofol.
- Secondary Outcome Measures
Name Time Method